Trilogy Analytical Laboratory Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 23-12-2024
- Paid Up Capital ₹ 1.17 Cr
as on 23-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Dec 2023
- Revenue 412.75%
(FY 2020)
- Profit 28.14%
(FY 2020)
- Ebitda 46.06%
(FY 2020)
- Net Worth -208.30%
(FY 2020)
- Total Assets 16.79%
(FY 2020)
About Trilogy Analytical Laboratory
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ryan Malone, Shivani Desai, and Rabindra Chakraborty serve as directors at the Company.
- CIN/LLPIN
U24132TG2015PTC098389
- Company No.
098389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2015
- Date of AGM
21 Jun 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Trilogy Analytical Laboratory Private Limited offer?
Trilogy Analytical Laboratory Private Limited offers a wide range of products and services, including Turnkey Consultants & Solutions, Project Handling Services, Research and Development (R&D) Work, Product Development Research, Computer and Mobile Softwares & Apps, Manufacturing Software.
Who are the key members and board of directors at Trilogy Analytical Laboratory?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivani Desai  | Director | 05-Apr-2021 | Current |
Ryan Malone  | Director | 22-Apr-2016 | Current |
| Rabindra Chakraborty | Director | 26-Apr-2021 | Current |
Financial Performance of Trilogy Analytical Laboratory.
Trilogy Analytical Laboratory Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 412.75% increase. The company also saw a substantial improvement in profitability, with a 28.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 208.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trilogy Analytical Laboratory?
In 2020, Trilogy Analytical Laboratory had a promoter holding of 56.40% and a public holding of 43.60%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chromogenic Life Sciences (India) Private LimitedActive 14 years 3 daysShivani Desai and Rabindra Chakraborty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Trilogy Analytical Laboratory?
Unlock and access historical data on people associated with Trilogy Analytical Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trilogy Analytical Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trilogy Analytical Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
